Aktie A3EGPV HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Huakang Biomedical Holdings Company Limited

Aktien

A3EGPV

KYG4644W1069

8622

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:09:09 25.04.2024 		% 5 Tage % 1. Jan.
0,101 HKD -4,72 % Intraday Chart für Huakang Biomedical Holdings Company Limited +1,00 % -5,61 %
28.03. Huakang Biomedical Holdings Company Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
25.03. Huakang Biomedical Holdings Company Limited gibt Konzerngewinnprognose für das am 31. Dezember 2023 endende Jahr ab CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023
An unknown buyer acquired 15.59% stake in Huakang Biomedical Holdings Company Limited from Ever Charming Inc for HKD 3.2 million.
Huakang Biomedical Holdings Company Limited Announces Change of Address of Head Office, Effect from 18 December 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Huakang Biomedical Holdings Company Limited Appoints Chow Ching Man as Independent Non-Executive Director Member of Audit Committee and Nomination Committee
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Huakang Biomedical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2021
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Three Months Ended March 31, 2021
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EGPV Aktie
  4. Nachrichten Huakang Biomedical Holdings Company Limited
  5. Andere Sprachen